Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans Henrik Parving
The Losartan Renal Protection Study--Rationale, Study Design and Baseline Characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan).
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Related publications
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Hypertension
Internal Medicine
Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.
Internal Medicine
Internal Medicine
Medicine
Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients
Gout and Nucleic Acid Metabolism
Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Rationale, Design, and Baseline Characteristics of the Cardiovascular Prognostic COUPLING Study in Japan (The COUPLING Registry)
Journal of Clinical Hypertension
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Study the Nephro-Protective Effects of Losartan on Rats
International Journal of Clinical Pharmacology & Pharmacotherapy
Subtypes of Losartan-Sensitive Angiotensin Receptor in the Rabbit Pulmonary Artery
British Journal of Pharmacology
Pharmacology
The Rationale, Design, and Baseline Characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)
Brain Research
Neuroscience
Neurology
Developmental Biology
Molecular Biology
Seasonal Dosage-Dependent Hypersensitivity to the Angiotensin II Receptor Blocker, Losartan. A Case Report and Review
